Pharmazz
Manufacturing · Illinois, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
50 75th St Ste 105, Willowbrook, Illinoi...Phone Number
(630) 780-6087Website
www.pharmazz.comRevenue
$7.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Pharmazz
Pharmazz, Inc. is a Delaware-based biopharmaceutical company focused on developing innovative therapies for critical care and neurological disorders. Established in 2010 and headquartered in Willowbrook, Illinois, Pharmazz operates globally, with a significant presence in India through its subsidiary, Pharmazz India Pvt LtdExplore more
Pharmazz Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pharmazz your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Pharmazz
Product Launch: Get notified when Pharmazz launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Pharmazz has new funding data
Pharmazz, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Pharmazz recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Pharmazz has recently received funding, and reach out quickly before it becomes old news!
Click to see if Pharmazz had a recent Job posting/layoffs
Check out if Pharmazz is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Pharmazz as Masked Content
Find more new buyers
Compare Similar Companies to Pharmazz
Compare insights from companies similar to Pharmazz, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pharmazz is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pharmazz is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pharmazz.
Pharmazz financials insights
Gather financial insights about Pharmazz, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Private Equity
$15M
2025
Private Equity
$25M
Pharmazz Tech Stack
A closer look at the technologies used by Pharmazz
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Pharmazz News & Media
Pharmazz Presents Positive Phase IV Interim Analysis of Sovateltide for Acute Ischemic Stroke at the International Stroke Conference 2026
WILLOWBROOK, Ill., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Pharmazz, Inc. today announced the presentation of positive interim results from its ongoing Phase IV clinical study of sovateltide (Tycamzzi®) in patients with acute cerebral ischemic stroke at the International Stroke Conference (ISC) 2026 in New Orleans.Pharmazz Inc. Announces Enrollment of First Patient in Phase 3 Clinical Trial of Sovateltide for Treating Patients with Cerebral Ischemic Stroke
The Phase 3 clinical trial of sovateltide, RESPECT-ETB, is expected to enroll over 500 patients with a primary endpoint of proportion of patients demonstrating functional independence at 90 days and is being conducted under a Special Protocol Assessment (SPA) with the FDA.Pharmazz Inc. Secures $25 Million Strategic Equity Investment from Sun Pharmaceutical Industries Ltd.
Funding supports pivotal Phase 3 trial for sovateltide, a potential first-in-class therapy that could transform the treatment of acute cerebral ischemic stroke Funding supports pivotal Phase 3 trial for sovateltide, a potential first-in-class therapy that could transform the treatment of acute cerebral ischemic strokeSun Pharma raises stake in US based Pharmazz, stock flat - BusinessToday
Sun Pharma stock was trading flat at Rs 1688.70 in early deals on Monday. Market cap of the pharma firm stood at Rs 4.04 lakh crore.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pharmazz
Sign Up For FreeTo access detailed company insights
Pharmazz, Inc. is a Delaware-based biopharmaceutical company focused on developing innovative therapies for critical care and neurological disorders. Established in 2010 and headquartered in Willowbrook, Illinois, Pharmazz operates globally, with a significant presence in India through its subsidiary, Pharmazz India Pvt Ltd... Read More
